448 - The diagnosis and management of hematologic malignancies during pregnancy
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
448 - The diagnosis and management of hematologic malignancies during pregnancy
00:00
00:00
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
エピソードの説明はありません。
公開日16 7月 2026
再生時間17:39
エピソード
448-
The diagnosis and management of hematologic malignancies during pregnancy
再生済み
16 7月 2026
447-
Hodgkin lymphoma in 2026: frontline strategies, ctDNA, and treatment after relapse
再生済み
10 7月 2026
446-
Sequencing BTK inhibitor therapy in CLL: treatment considerations and emerging strategies
再生済み
30 6月 2026
445-
Precision medicine in AML: from targeted therapy to transplantation
再生済み
22 6月 2026
444-
MPNs in focus: disease progression, risk assessment, and emerging treatments
再生済み
15 6月 2026
443-
The evolving role of cellular therapies and T-cell engagers in lymphoma
再生済み
29 5月 2026
442-
Multiple myeloma in 2026: MRD, BCMA therapies, CAR-T, and the path to cure
再生済み
22 5月 2026
441-
Dual-targeting CAR T-cell therapies in LBCL: efficacy, safety, and bridging therapy
再生済み
15 5月 2026
440-
Advances in gene-based therapies for SCD and thalassemia: access, outcomes & innovation
再生済み
08 5月 2026
439-
The evolving role of BTK inhibitors in CLL
再生済み
01 5月 2026
438-
Adverse events in the post-CAR T-cell therapy setting: infections, less common toxicities, and advice for physicians
再生済み
24 4月 2026
437-
The evolving treatment landscape in MCL: chemo-free strategies, BTK inhibitors, and changing standards of care
再生済み
16 4月 2026
436-
Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
再生済み
09 4月 2026
435-
Myeloid Monthly: breaking news & updates from the classification advancement meeting
再生済み
02 4月 2026
434-
How AI is transforming hematologic oncology
再生済み
27 3月 2026
433-
MRD in ALL and AML: from prognostic marker to clinical endpoint
再生済み
20 3月 2026
431-
Nursing in CAR-T & cellular therapy: updates and insights from the EBMT-EHA CAR T-cell Meeting 2026
再生済み
27 2月 2026
430-
Recent BTK inhibitor trial updates across non-Hodgkin lymphoma subtypes
再生済み
20 2月 2026
429-
ASH 2025 highlights in AL amyloidosis: risk stratification, bispecific antibodies, CAR-T, & MRD
再生済み
06 2月 2026
428-
Top ASH 2025 updates in AML: redefining frontline therapy, menin inhibition, venetoclax-based triplets, & emerging immunotherapies
再生済み
30 1月 2026
427-
Managing and preventing differentiation syndrome in APL
再生済み
22 1月 2026
426-
Top ASH 2025 NHL updates: novel CAR T-cell therapies, fixed-duration strategies, evolving frontline approaches, & more
再生済み
16 1月 2026
425-
Top updates in myeloma from ASH 2025: the RedirecTT-1 and MajesTEC-3 trials, dual-targeting CAR-T, trispecific antibodies, and more!
再生済み
09 1月 2026
424-
Top CLL updates from ASH 2025: novel BTKi monotherapy and combination approaches, BTK degraders, & more
再生済み
18 12月 2025
423-
Top updates in MDS from ASH 2025: key trial updates and debated topics
再生済み
12 12月 2025
422-
Sickle cell disease management: navigating the transition from pediatric to adult care, managing VOCs, & more
再生済み
27 11月 2025
421-
Accelerated- and blast-phase MPNs: diagnosis, management, and current challenges
再生済み
20 11月 2025
420-
The value and utility of MRD in the management of adults with newly-diagnosed AML
再生済み
14 11月 2025
419-
Updates from iwHRMM: targeted and immune-related therapies and mechanisms of resistance
再生済み
07 11月 2025
418-
Advances in immunotherapy for NHL: updates from iwNHL 2025
再生済み
31 10月 2025
417-
Reviewing recent guideline updates on the risk stratification and treatment of AML
再生済み
16 10月 2025
416-
The management of CLL in resource-limited settings: guideline development and ongoing projects
再生済み
16 10月 2025
415-
The multi-disciplinary team in CAR-T therapy: insights from a nurse, a neurologist, and a palliative care specialist
再生済み
29 9月 2025
414-
Understanding financial and time toxicity in cancer care: advice for community oncologists
再生済み
19 9月 2025
413-
Listener Q&A special: expert insights on CLL, myeloma, and lymphoma
再生済み
12 9月 2025
412-
Novel strategies and advances in the management and classification of MDS: insights from iwMDS 2025
再生済み
04 9月 2025
411-
Advances in Waldenström’s macroglobulinemia: significance of genetic alterations, current treatment strategies, & ongoing trials
再生済み
20 8月 2025
410-
FLT3-ITD+ AML: recent trial updates, novel approaches, and MRD
再生済み
15 8月 2025
409-
Extramedullary disease in multiple myeloma: biology, management strategies, & the RedirecTT-1 trial
再生済み
08 8月 2025
408-
iwMPN 2025 highlights: novel approaches to the upfront management of myelofibrosis, cardiovascular health in MPNs, & more
再生済み
01 8月 2025
407-
Managing CNS lymphoma: expert insights and updates from ICML 2025
再生済み
29 7月 2025
406-
iwMDS wrap-up: translating research into practice to optimize patient care
再生済み
18 7月 2025
405-
Targeting mutant CALR in MPNs with antibodies & cellular therapy: the potential for disease modification
再生済み
14 7月 2025
404-
Treating elderly or unfit patients with AML: current approach and future directions